Cassandra Koole
Geelong, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Socs3b regulates the development and function of innate immune cells in zebrafish.
Journal: Frontiers in immunology
Published: December 09, 2022
Structure and Dynamics of Adrenomedullin Receptors AM1 and AM2 Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying Proteins.
Journal: ACS pharmacology & translational science
Published: October 08, 2019
Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.
Journal: Molecular cell
Published: June 18, 2019
Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor.
Journal: Nature
Published: June 01, 2018
Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism.
Journal: The Journal of biological chemistry
Published: April 02, 2018
Vascular and molecular pharmacology of the metabolically stable CGRP analogue, SAX.
Journal: European journal of pharmacology
Published: February 19, 2018
Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex.
Journal: Nature
Published: September 22, 2017
Genetically encoded photocross-linkers determine the biological binding site of exendin-4 peptide in the N-terminal domain of the intact human glucagon-like peptide-1 receptor (GLP-1R).
Journal: The Journal of biological chemistry
Published: February 01, 2017
Allostery and Biased Agonism at Class B G Protein-Coupled Receptors.
Journal: Chemical reviews
Published: April 05, 2016
The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased Agonism.
Journal: Cell
Published: December 01, 2015
A Hydrogen-Bonded Polar Network in the Core of the Glucagon-Like Peptide-1 Receptor Is a Fulcrum for Biased Agonism: Lessons from Class B Crystal Structures.
Journal: Molecular pharmacology
Published: August 04, 2015
Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery.
Journal: The Journal of pharmacology and experimental therapeutics
Published: January 30, 2015
Last Updated: 09/26/2026